Document is current
Any future updates will be listed below
-
Authors
Ferrández, Maria C.
Golla, Sandeep S. V.
Eertink, Jakoba J.
de Vries, Bart M.
Wiegers, Sanne E.
Zwezerijnen, Gerben J. C.
Pieplenbosch, Simone
Schilder, Louise
Heymans, Martijn W.
Zijlstra, Josée M.
Boellaard, Ronald
-
Funding
Funding for this research was provided by:
Hanarth Fonds
KWF Kankerbestrijding (VU-2018-11648)
- License Information
-
More Information
Article History
Received: 5 July 2023
Accepted: 19 September 2023
First Online: 28 September 2023
Declarations
:
: This study was conducted in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments. Ethics approval was obtained by the Medical Ethics Review Committee of Amsterdam UMC, location VUmc (IRB2018.029) and the department of Hematology of the Amstelland Hospital in Amstelveen (IRB2019.278). Informed consent was waived given the retrospective nature of the study.
: Not applicable.
: This work was financially supported by the Hanarth Fonds Fund and the Dutch Cancer Society (#VU-2018–11648). M.C.F., S.S.V.G, J.J.E., B.M.d.V., S.E.W., G.J.C.Z., S.P. and R.B. declare no competing financial interests. J.M.Z. received research funding from Roche and received honoraria for advisory boards from Takeda, Gilead, BMS and Roche. No other potential conflicts of interest relevant to this article exist.
